Back to Journals » OncoTargets and Therapy » Volume 9

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Total article views   HTML views PDF downloads Totals
8,004 Dovepress* 6,134+ 1,242 7,376
PubMed Central* 1,870 316 2,186
Totals 8,004 1,558 9,562
*Since 21 July 2016

View citations on PubMed Central and Google Scholar